Elixir Floral n°7 Chestnud bud/Bourgeons de marronier 10 mL
Food supplement declared in France, declaration No 2018-2-442, decision dated 9 February 2018
Elixir Floral n°7 Chestnud bud/Bourgeons de marronier 10 mL (INEBIOS) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Aesculus hippocastanum 0.000125 ml per day. None of the rules we check flags an issue with its declared composition.
- Brand
- INEBIOS
- Food business operator placing the product on the market
- Laboratoires Inebios S.A.S.
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Dropper
- Daily dose
- 12 gouttes
- Directions for use
- 3 gouttes sous la langue
- Not recommended (according to the manufacturer)
- Breastfeeding women, Pregnant women
- Objectives stated by the manufacturer (these are not authorised claims)
- Mood
Declaration 286325, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Aesculus hippocastanum L. | Bourgeon | Extrait fluide hydroalcoolique | 0.000125 ml |
Other ingredients
Cognac
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
En complément d’une alimentation variée et équilibrée et d’un mode de vie sain. Ne pas dépasser la dose conseillée. Tenir hors de portée des enfants. Utiliser avec modération pendant la grossesse et l’allaitement. Déconseillé aux personnes souffrant d’éthylisme.
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Aesculus hippocastanum L.
Read the warning, when it applies and the studies cited
Horse Chestnut - Aesculus Hippocastanum
Route of administration: Oral (Bradley 2006; ESCOP 2003)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Brinker 2010; Mills and Bone 2005).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Known adverse reactions
When using this product you may experience headache, dizziness, gastric irritation, or itchiness (Bradley 2006; Mills and Bone 2005; ESCOP 2003).
Sources cited by Health Canada (3)
- Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (UK): British Herbal Medicine Association; 2006.
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : INEBIOS
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Elixir Floral n°7 Chestnud bud/Bourgeons de marronier 10 mL (INEBIOS): composition and regulation”, https://compoatlas.com/en/supplements/products/286325-elixir-floral-n-7-chestnud-bud-bourgeons-de-marronier-10-ml, updated 15 November 2026.